|
INN ▲
|
ATC Code ▲
|
Classification ▼
|
Last update ▲
|
|
NEFAZODONE |
N06AX06 |
I
|
19-09-2007 |
|
NELFINAVIR |
J05AE04 |
I
|
|
|
NEOMYCIN |
A07AA01 |
I
|
14-10-2003 |
|
NEOMYCIN |
J01GB05 |
I
|
14-10-2003 |
|
NEOMYCIN |
S02AA07 |
I
|
14-10-2003 |
|
NEOMYCIN |
S03AA01 |
I
|
01-03-2005 |
|
NERATINIB |
L01EH02 |
I
|
|
|
NETILMICIN |
J01GB07 |
I
|
|
|
NIMESULIDE |
M01AX17 |
I
|
16-09-2003 |
|
NIMUSTINE |
L01AD06 |
I
|
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
I
|
|
|
NIRSEVIMAB |
J06BD08 |
I
|
|
|
NITISINONE |
A16AX04 |
I
|
|
|
NITRAZEPAM |
N05CD02 |
I
|
27-09-2006 |
|
NITRIC OXIDE |
R07AX01 |
I
|
16-09-2003 |
|
NITROFURAL |
B05CA03 |
I
|
14-10-2003 |
|
NITROFURANTOIN |
J01XE01 |
I
|
01-03-2005 |
|
NITROGEN |
V03AN04 |
I
|
22-05-2019 |
|
NIVOLUMAB |
L01FF01 |
I
|
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
I
|
|
|
NOMEGESTROL |
G03DB04 |
I
|
|
|
NOREPINEPHRINE |
C01CA03 |
I
|
|
|
NORETHISTERONE AND ESTROGEN |
G03FA01 |
I
|
21-03-2006 |
|
NORETHISTERONE AND ESTROGEN |
G03FB05 |
I
|
21-03-2006 |
|
NORFENEFRINE |
C01CA05 |
I
|
14-10-2003 |
|
NORFLOXACIN |
J01MA06 |
I
|
05-11-2022 |
|
NORGESTREL AND ESTROGEN |
G03FB01 |
I
|
21-03-2006 |
|
NORGESTREL AND ETHINYLESTRADIOL |
G03AA06 |
I
|
21-03-2006 |
|
NORTRIPTYLINE |
N06AA10 |
I
|
19-09-2007 |
|
NYSTATIN |
A07AA02 |
I
|
21-03-2006 |
|
NYSTATIN, COMBINATIONS |
G01AA51 |
I
|
23-11-2023 |
|
OBIDOXIME |
V03AB13 |
I
|
22-05-2019 |
|
OBILTOXAXIMAB |
J06BC04 |
I
|
|
|
OBINUTUZUMAB |
L01FA03 |
I
|
|
|
OCRELIZUMAB |
L04AG08 |
I
|
|
|
OFATUMUMAB |
L01FA02 |
I
|
|
|
OFATUMUMAB |
L04AG12 |
I
|
|
|
OFLOXACIN |
J01MA01 |
I
|
05-11-2022 |
|
OLANZAPINE |
N05AH03 |
I
|
|
|
OLAPARIB |
L01XK01 |
I
|
|
|
OLEANDOMYCIN |
J01FA05 |
I
|
05-03-2003 |
|
OLIPUDASE ALFA |
A16AB25 |
I
|
|
|
OMBITASVIR, PARITAPREVIR AND RITONAVIR |
J05AP53 |
I
|
|
|
ONASEMNOGENE ABEPARVOVEC |
M09AX09 |
I
|
|
|
ONDANSETRON |
A04AA01 |
I
|
|
|
ORITAVANCIN |
J01XA05 |
I
|
23-05-2024 |
|
ORNIDAZOLE |
J01XD03 |
I
|
28-07-2004 |
|
OSIMERTINIB |
L01EB04 |
I
|
|
|
OXABOLONE CIPIONATE |
A14AB03 |
I
|
|
|
OXACEPROL |
M01AX24 |
I
|
|